Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DFL-24412 by Dompe Farmaceutici for Chronic Low Back Pain (CLBP): Likelihood of Approval
DFL-24412 is under clinical development by Dompe Farmaceutici and currently in Phase II for Chronic Low Back Pain (CLBP). According...